Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317107683> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W4317107683 endingPage "A043" @default.
- W4317107683 startingPage "A043" @default.
- W4317107683 abstract "Abstract Metastasis of cancer cells to secondary sites remains the leading cause of cancer related deaths, emphasizing a strong need for actionable targets in advanced stage cancer. To address this, we study novel dysregulated signaling mechanisms that cells utilize to metastasize to distal sites. Here, we focus on how outer mitochondrial membrane protein—Mitochondrial Rho GTPase 2 (MIRO2)—promotes tumor cell invasion and metastasis through a negative regulation of RhoA. Our previous work identified higher MIRO2 mRNA expression in cancer vs. normal patient samples, which correlated with worse patient outcomes. Furthermore, in the context of prostate cancer we demonstrated that MIRO2 was critical for 2D cell growth, anchorage-dependent and -independent colony formation, and tumor growth in vivo. However, it remains completely unknown if MIRO2 affects primary tumor growth or if this protein is important throughout tumor progression. Using siRNA mediated knockdown (KD) of MIRO2 we clearly show that MIRO2 KD ubiquitously reduces tumor cell invasion in breast, melanoma, pancreatic, and prostate cancer cell lines. Preliminary experiments modeling late-stage metastasis showed that tail vein injection of PC3 cells stably expressing MIRO2 targeting shRNA had reduced kidney and liver metastatic burden in comparison to PC3 cells with control shRNA. In further mechanistic studies, we identified novel MIRO2 binding partners and used siRNA to KD the top hits and observe changes in invasive capacity. We found that atypical myosin IX B (MYO9B) reduced the invasion of cells to the largest extent. MYO9B is a plus-end direct atypical myosin known to control cell motility through spatially inactivating RhoA at the leading edge of migrating cells. Excitingly, MIRO2 KD showed an increase in active RhoA phenocopying MYO9B KD. Lastly, in pilot experiments we found that dual KD of MIRO2 and RhoA rescued invasive capacity in comparison to MIRO2 KD alone. Taken together, we propose a novel signaling mechanism by which MIRO2 broadly promotes invasion and metastasis through MYO9B dependent inactivation of RhoA. Citation Format: Dillon P. Boulton, Madison Furnish, M. Cecilia Caino. A novel role for Mitochondrial Rho GTPase 2 in tumor cell invasion and metastasis [abstract]. In: Proceedings of the AACR Special Conference: Cancer Metastasis; 2022 Nov 14-17; Portland, OR. Philadelphia (PA): AACR; Cancer Res 2022;83(2 Suppl_2):Abstract nr A043." @default.
- W4317107683 created "2023-01-18" @default.
- W4317107683 creator A5020991569 @default.
- W4317107683 creator A5023557774 @default.
- W4317107683 creator A5068973959 @default.
- W4317107683 date "2023-01-15" @default.
- W4317107683 modified "2023-09-29" @default.
- W4317107683 title "Abstract A043: A novel role for Mitochondrial Rho GTPase 2 in tumor cell invasion and metastasis" @default.
- W4317107683 doi "https://doi.org/10.1158/1538-7445.metastasis22-a043" @default.
- W4317107683 hasPublicationYear "2023" @default.
- W4317107683 type Work @default.
- W4317107683 citedByCount "0" @default.
- W4317107683 crossrefType "journal-article" @default.
- W4317107683 hasAuthorship W4317107683A5020991569 @default.
- W4317107683 hasAuthorship W4317107683A5023557774 @default.
- W4317107683 hasAuthorship W4317107683A5068973959 @default.
- W4317107683 hasConcept C121608353 @default.
- W4317107683 hasConcept C137738243 @default.
- W4317107683 hasConcept C1491633281 @default.
- W4317107683 hasConcept C173396325 @default.
- W4317107683 hasConcept C190232843 @default.
- W4317107683 hasConcept C2777093181 @default.
- W4317107683 hasConcept C2779013556 @default.
- W4317107683 hasConcept C502942594 @default.
- W4317107683 hasConcept C54355233 @default.
- W4317107683 hasConcept C62478195 @default.
- W4317107683 hasConcept C81885089 @default.
- W4317107683 hasConcept C86803240 @default.
- W4317107683 hasConcept C95444343 @default.
- W4317107683 hasConcept C96232424 @default.
- W4317107683 hasConceptScore W4317107683C121608353 @default.
- W4317107683 hasConceptScore W4317107683C137738243 @default.
- W4317107683 hasConceptScore W4317107683C1491633281 @default.
- W4317107683 hasConceptScore W4317107683C173396325 @default.
- W4317107683 hasConceptScore W4317107683C190232843 @default.
- W4317107683 hasConceptScore W4317107683C2777093181 @default.
- W4317107683 hasConceptScore W4317107683C2779013556 @default.
- W4317107683 hasConceptScore W4317107683C502942594 @default.
- W4317107683 hasConceptScore W4317107683C54355233 @default.
- W4317107683 hasConceptScore W4317107683C62478195 @default.
- W4317107683 hasConceptScore W4317107683C81885089 @default.
- W4317107683 hasConceptScore W4317107683C86803240 @default.
- W4317107683 hasConceptScore W4317107683C95444343 @default.
- W4317107683 hasConceptScore W4317107683C96232424 @default.
- W4317107683 hasIssue "2_Supplement_2" @default.
- W4317107683 hasLocation W43171076831 @default.
- W4317107683 hasOpenAccess W4317107683 @default.
- W4317107683 hasPrimaryLocation W43171076831 @default.
- W4317107683 hasRelatedWork W2040352400 @default.
- W4317107683 hasRelatedWork W2081501617 @default.
- W4317107683 hasRelatedWork W2105309670 @default.
- W4317107683 hasRelatedWork W2119078898 @default.
- W4317107683 hasRelatedWork W2391617054 @default.
- W4317107683 hasRelatedWork W3001922991 @default.
- W4317107683 hasRelatedWork W3005333056 @default.
- W4317107683 hasRelatedWork W3045584038 @default.
- W4317107683 hasRelatedWork W3049178086 @default.
- W4317107683 hasRelatedWork W3119915123 @default.
- W4317107683 hasVolume "83" @default.
- W4317107683 isParatext "false" @default.
- W4317107683 isRetracted "false" @default.
- W4317107683 workType "article" @default.